Lin Bioscience Stock

Lin Bioscience EBIT per Share

The EBIT per Share of Lin Bioscience (6696.TWO) as of Sep 5, 2026 is -35.07 TWD. In the previous year, EBIT per Share was -18.54 TWD — a change of 89.16% (lower).

EBIT per Share

-35.07TWD

YoY

89.16%

Last updated:

EBIT per Share of Lin Bioscience is 2026 -35.07 TWD. EBIT per Share of Lin Bioscience was 2025 -18.54 TWD. It decreases by 89.16% lower compared to the previous year.

The Lin Bioscience EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2016
-1.52 TWD
Jan 1, 2017
-2.84 TWD
Jan 1, 2018
-2.52 TWD
Jan 1, 2022
-6.09 TWD
Jan 1, 2023
-14.57 TWD
Jan 1, 2024
-18.54 TWD
Jan 1, 2025
-35.07 TWD
The Lin Bioscience EBIT per Share history
YEAREBIT per ShareYoY
-35.07TWD+89.16%
-18.54TWD+27.27%
-14.57TWD+139.15%
-6.09TWD+141.22%
-2.52TWD-11.19%
-2.84TWD+86.54%
-1.52TWD—
Access this data via the Eulerpool API
Get Free API Key

Lin Bioscience Stock analysis

What does Lin Bioscience do? Lin Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lin Bioscience stock

EBIT per Share of Lin Bioscience is -35.07 TWD in 2026.

EBIT per Share of Lin Bioscience changed from -18.54 TWD to -35.07 TWD, representing a 89.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Lin Bioscience since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Lin Bioscience

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Lin Bioscience